Clinical trial
Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
NCT01790152 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
- Lead sponsor
- Children's Oncology Group
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 5, 2014
- Completion date
- December 31, 2026
- Enrollment
- 420 (estimated)
- Sites
- 79
Conditions
As the registry lists them; a condition with its own page is linked.
hodgkin lymphoma in remission, leukemia in remission, lymphoblastic lymphoma, osteosarcoma, recurrent leukemia, recurrent lymphoma, recurrent malignant neoplasm